Aktis Oncology, Inc. (AKTS) Q2 2024 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Aktis Oncology, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.029 -- 00:00:04.610 Good day, ladies and gentlemen, and welcome to Acoustics Technologies' 00:00:04.810 -- 00:00:07.891 fiscal 2024 second quarter conference call. 00:00:07.891 -- 00:00:10.791 As a reminder, this conference is being recorded. 00:00:10.791 -- 00:00:16.192 At the conclusion of the company's presentation, Acoustics Management will take questions. 00:00:16.192 -- 00:00:21.213 To ask a question, please press star 1 on your telephone keypad to be placed into the 00:00:21.213 -- 00:00:26.354 queue. A replay of the call will be available on the Investor Relations section 00:00:26.354 -- 00:00:30.492 of Acoustics' website. Thank you. You may begin. 00:00:30.492 -- 00:00:33.634 Thank you, Operator, and good morning to everyone on the call. 00:00:33.634 -- 00:00:37.958 Welcome to Acoustics' second quarter fiscal 2024 conference call. 00:00:37.958 -- 00:00:43.462 I am Ken Bowler, CFO, and I'm joined today by our founder and CEO, Jeff Shealy, and EVP 00:00:43.462 -- 00:00:48.486 of Business Development, Dave Eichle. Before we begin, please note that today's presentation 00:00:48.486 -- 00:00:52.029 includes forward-looking statements about our business outlook. 00:00:52.029 -- 00:00:55.732 All statements other than statements of historical facts included in this conference 00:00:55.732 -- 00:01:00.926 call, such as expectations regarding our strategies and operations, including 00:01:00.926 -- 00:01:06.090 the timing and prospects of product development and customer orders and design wins, 00:01:06.090 -- 00:01:11.333 possible collaborative or partnering relationships, litigation matters, and expected 00:01:11.333 -- 00:01:15.636 financial and operating results are forward-looking statements. 00:01:15.636 -- 00:01:20.639 Such forward-looking state...